Ernexa Therapeutics ERNA Q3 2023 Earnings ClinicalStage Biotech Reports Net Loss as Stock Declines RenaissanceRe Holdings Ltd RNR Q1 2026 Earnings Strong Underwriting Drives EPS Beat of 23 MAC Q1 2026 Earnings EPS Misses Estimates as Retail Headwinds Persist VEON Q1 2026 Earnings Earnings Beat Expectations Despite Lack of Revenue Disclosure STRL Q1 2026 Earnings Stellar EPS Surprise of 506 Despite Negative Market Reaction AMST Q1 2026 Earnings Loss Per Share of 016 as Shares Decline Sharply